R Squared’s Anterix ATEX Stock Holding History

R Squared’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-250	Closed	-$7.67K	–	388
2024 Q4	$7.67K	Buy	+250	New	+$8.31K	0.01%	1220

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

GECH

Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

R Squared's ATEX Position: Q1 2025 in Review

R Squared sold out of Anterix (ATEX) in Q1 2025, closing a stake of 250 shares — an estimated $7.67K sold.

R Squared first reported a position in ATEX in Q4 2024 and held it in 1 quarter. The position peaked at $7.67K in Q4 2024. 128 funds tracked by Wall St. Rank hold ATEX as of Q1 2025.

R Squared reported no remaining Anterix position as of Q1 2025 after selling out during the quarter.
R Squared sold 250 Anterix shares in Q1 2025, an estimated $7.67K.
R Squared first reported a position in Anterix in Q4 2024 and held it in 1 quarter.
R Squared's Anterix position peaked at $7.67K in Q4 2024.
128 funds tracked by Wall St. Rank held Anterix as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.